Investors, executives, financial and service professionals, journalists and other interested individuals are invited to hear from leading experts concerning evolving international markets for nanomedicine, micromachines, and nanomaterials. Discussion will focus on identifying the drivers that will influence the convergence of nano- and bio- technology and the pockets of excellence around the world that are developing commercially viable products. Additional attention will be directed toward the factors that are currently hampering the growth of this promising market.

To register online, please visit:

http://www.cvent.com/EventManagement/Invitations/

This event will be held on June 27, 2002 from 8:00 am-11:00 am at the Law Offices of McDermott, Will & Emery, 50 Rockefeller Plaza, New York, NY. The audience will include a select group of officials representing international trade and investment organizations, as well as venture capital and private equity professionals, technology and research experts, professional service providers, and global entrepreneurs.

Kishore Mahbubani, Ambassador from Singapore to the United Nations will begin the session with a keynote addressing the challenges of convergence and adapting to change. The Ambassador is the author of the widely-acclaimed and provocative book "Can Asians Think? Understanding the Divide Between East and West".

The panel discussion moderated by Andrew Sherman, of McDermott, Will & Emery will include financial, technical, and business development thought leaders, including:

• Dr. Uri Sagman, C Sixty, Inc.
• Zohar Peri Economic Minister to North America, Government of Israel
• Robert Muir, Investment Commissioner, Invest Australia
• Rick Savone, Consul and Trade Commissioner (Biosciences), Canadian Government Trade Office
• Peter Hauptmann, COO, Saarland (Germany) Economic Promotion Corp.
• Neil Gordon, President, Canadian NanoBusiness Alliance & Partner, Nanotechnology Sygertech
• David Dempsey, Bentley Associates
• Keith Rabin, KWR International, Inc.
• Dr. Alan Manevitz, Doctors Investment Fund, LLC
• Dr. Nathan Tinker, Co-Founder and EVP, NanoBusiness Alliance

Following the panel discussion, John W. Allen, CEO, Turtlesnap Ventures will lead a discussion to identify key areas of interest to be explored in the Second Annual Turtlesnap Global Trends Investment Symposium scheduled for Fall 2002.

This event is sponsored by McDermott, Will and Emery with support from KWR International, Inc.

"We are eager to hear from visionaries like Toronto-based Dr. Uri Sagman who is developing nano drug delivery systems for fighting cancer and AIDS," said Karen Jagoda, President and COO, Turtlesnap Ventures. "We want to encourage international investors to view nanotech as an enabling technology rather than just the latest hot sector."

"This event seeks to recognize the prominent role that nanotech and biotech is playing in expanding the frontiers of medical science," noted Andrew Sherman, Partner of McDermott, Will & Emery. "Rapid progress is raising a wide range of regulatory issues that need to be examined within the context of the many investment and commercial opportunities that are emerging."

"While investors are increasingly interested in nano- and bio- technology, current market conditions are contributing to a reluctance to assume the risks in advancing important developments," stated Keith Rabin, President, KWR International. "Our discussion will seek to identify the strategies and business models that countries and companies can use to help attract funding and sustain their ability to compete over the long term."